Catabasis Pharmaceuticals, Inc. appointed Noah Clauser, the company’s Vice President, Finance as the company’s principal financial officer, effective December 17, 2019. Mr. Clauser has served as the company’s Vice President, Finance and led the company’s finance and operations functions since August 2017. Previously, he served as Senior Director, Finance and Controller of the company from January 2016 to August 2017 and as Controller of the company from April 2011 to December 2015. Mr. Clauser is a licensed Certified Public Accountant in Massachusetts and holds an M.S. in Accounting and a B.S. in Management from the University of Massachusetts at Boston. Upon Mr. Clauser’s appointment, Dr. Jill C. Milne, the company’s President and Chief Executive Officer, voluntarily resigned her position as the company’s principal financial officer. Dr. Milne will continue to maintain her leadership position as President and Chief Executive Officer and her directorship role on the company board.